Impact of donor and recipient age on allograft tolerance.
The elderly represent the fastest growing segment of the population with end-stage organ disease and the use of aged grafts increased exponentially. Since aging of the immune system, or "immunosenscence" is generally associated with weaker immune responses, one might expect the elderly to be less reactive against transplanted organs than younger patients and therefore to showbetter results in terms of transplant outcome. Paradoxically, however, experimental studies and clinical data of organ transplantation show that old age of either the recipient or the donor is associated with poorer outcomes. On the other hand transplant tolerance is easier to be induced in the neonatal period. One potential reason for this discrepancy may lie in the effects of immunosenescence on the induction of tolerance. While the impact of aging on acute and chronic allograft rejection has been extensively studied, its role on establishing transplant tolerance is not well known. Since tolerance is an active process, and not just the absence of an immune response, the immunologic changes associated with the aging process may interfere with graft survival. In experimental and clinical transplantation, most successful tolerance induction protocols have been tested on young individuals, using grafts from young donors. However, some experiments that have utilized aged animals have demonstrated resistance to tolerance induction. Extrapolation of these results to humans suggests that protocols for clinical tolerance induction may not be effective in the elderly and may need to be revised for this population. The resistance to achieving immunological tolerance with aging is complex and multifactorial. Here, we review the age associated changes that may interfere with immunologic tolerance. Understanding this phenomenon may help in developing novel therapeutic approaches to reverse the crucial dysfunctions of the aging immune system and achieve effective tolerance regimens for the elderly.
Martins
Paulo N
PN
Department of Surgery, Transplant Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Paulo_Martins@nymc.edu
D000375:Aging / Q000276:immunology* / Q000502:physiology; D000818:Animals; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007107:Immune System / Q000276:immunology / Q000502:physiology; D007108:Immune Tolerance / Q000276:immunology* / Q000502:physiology; D023421:Models, Animal; D016377:Organ Transplantation; D014019:Tissue Donors; D014180:Transplantation